jjulio3693
New
I need help understanding the JZ modifier (went into effect 07/01/2023). I have a Fact sheet from the AAO and it is confusing me and maybe I am overthinking it. The Fact Sheet says JZ is to be used on all claims that bill for drugs supplied as single-dose vials. Then it says report JZ modifier when the actual dose of the drug from a single-dose vial is less than the billing unit based on the HCPCS descriptor. Our office does lots of Avastin and Eylea injects, both are single dose so my thinking is that I would use the JZ. If anyone has any insight I would really appreciate it.